NIH-funded research R01 grant

Finding genes linked to intellectual disability in families from Africa, Asia, and Europe

Official title: Elucidating the Genetic Etiology of Intellectual Disability in African, Asian, and European Families

Funded at Columbia University Health Sciences · NIH-11164594 · Data updated 2026-11-12

This project looks for genetic changes that may cause intellectual disability by sequencing DNA from affected adults and their family members from African, Asian, and European backgrounds.

More Disability research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 14, 2023
Project endJuly 31, 2028
Funding year2025
Award (this year)$630,071
NIH project number5R01HD109342-03
Project IDNIH-11164594 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+) with intellectual disability and their family members from the enrolled populations (Finland, Hungary including Romani and Magyar groups, Mali, and Pakistan) who do not have Fragile X or a known environmental cause are ideal candidates.

Less likely to help

People whose intellectual disability is already explained by a known Fragile X expansion or by clear environmental causes will be excluded and are unlikely to benefit from this project.

What this research studies

Researchers will enroll about 500 families from Finland, Hungary (Romani and Magyar populations), Mali, and Pakistan and collect DNA from affected adults and their relatives. They will focus on trios (an affected person and both parents) and extended families, including those with consanguinity, while excluding cases with Fragile X or clear environmental causes. Teams will perform next-generation sequencing and use bioinformatics tools to flag rare, damaging variants and check whether those variants track with disability across family members. Promising candidate variants will be validated in the lab and tested for inheritance patterns within the families.

Why it matters

Potential benefit: If successful, this work could improve genetic diagnosis, counseling, and pave the way for future targeted treatments for people with intellectual disability.

How similar studies have gone: Previous large-scale sequencing studies have already identified over 1,000 genes for intellectual disability, so this gene-discovery approach has a strong track record but continues to seek genes that remain undiscovered.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Leal, Suzanne M — Columbia University Health Sciences
  • Study coordinator: Leal, Suzanne M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.